Search for: "Lambert v. USA" Results 21 - 40 of 60
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Mar 2018, 6:38 am
| Yet another horse – The Polo/Lauren Company L.P. v Royal County of Berkshire Polo Club Ltd. [read post]
26 Jan 2015, 4:03 am
She has now learned that the EPO has responded in the form of an email sent by Mr Guillaume Minnoye, Vice-President of Directorate General 1, which Merpel leaks here in all its majestic unbelievability.* No pain for Actavis: Warner-Lambert fail to stop launch of generic pregabalinSecond medical use claims, skinny labels, and public policy issues around healthcare are the topics addressed in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015]… [read post]
16 Mar 2015, 3:10 am
| Dutch Minister and EPO immunity | CJEU and droit de suite in Case C-41/14 Christie's France | Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others | Pangyrus Ltd v OHIM, RSVP Design Ltd | China and smartphone patents | UK against groundless threats to sue for IP infringement | Polar bears | Patent needs strictness, complexity and fuzziness. [read post]
8 Jun 2015, 4:20 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 48 [week ending on Sunday 31 May] - The meaning of EPO appeal system | 3D Printing and the law | Epo and external investigation firms | Umbrella designs | US Supreme Court in Commil USA, LLC v Cisco Systems | European Inventor Award | FIFA and brand integrity | Warner-Lambert v Actavis |  Wine in Black GmbH v OHIM | IP and… [read post]
22 Jun 2015, 9:24 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 50 [week ending on Sunday 7 June] - Swiss claims | Italian-sounding trade marks for cosmetics | “IP litigation and Enforcement” event | Saving WiFi | Spy scandal at the EPO | Rihanna v DC Comics | KitKat trade mark | Taste trade marks in the Netherlands | Connectivity and human rights | Trade secrets, client confidentiality and privilege | 3-d printing and counterfeiting | Ericsson v… [read post]
29 Nov 2018, 4:08 am by Edith Roberts
Lambert, which involves the timeliness of an appeal from a denial of class-action certification. [read post]
20 Mar 2018, 10:59 am
Strong brands as a barrier to entry, this time from "The Economist" | UK IPO publishes consultation on implementing Trade Mark Directive 2015 into UK law | Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle | EPO looking for new legally qualified members of the Boards of Appeal | Repair or reconstruction: Where do you draw the line for exhaustion under patent law? [read post]
26 Mar 2018, 9:14 am
Strong brands as a barrier to entry, this time from "The Economist" | UK IPO publishes consultation on implementing Trade Mark Directive 2015 into UK law | Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle | EPO looking for new legally qualified members of the Boards of Appeal | Repair or reconstruction: Where do you draw the line for exhaustion under patent law? [read post]
20 Jun 2018, 5:00 pm by John Elwood
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
8 Mar 2018, 6:48 am
Strong brands as a barrier to entry, this time from "The Economist" | UK IPO publishes consultation on implementing Trade Mark Directive 2015 into UK law | Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle | EPO looking for new legally qualified members of the Boards of Appeal|Repair or reconstruction: Where do you draw the line for exhaustion under patent law? [read post]
9 Nov 2011, 9:37 am by Conor McEvily
  The opinion prompted coverage from nearly every major news outlet, including Joan Biskupic of the USA Today, Tom Schoenberg and Andrew Harris of Bloomberg News, Jennifer Haberkorn of Politico, Nedra Pickler of the Associated Press, Jeremy Pelofsky and Lisa Lambert of Reuters, Noam M. [read post]
15 Oct 2017, 7:59 pm
In the Warner-Lambert case the Supreme Court was prepared to admit experimental data after the filing date, but only if certain conditions were met. [read post]